RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Amol Kulkarni to Drug Design

Back to Details
This is a "connection" page, showing publications Amol Kulkarni has written about Drug Design.
Amol Kulkarni
Connection Strength
0.124
Drug Design
  1. Xu Q, Kulkarni AA, Sajith AM, Hussein D, Brown D, G?ner OF, Reddy MD, Watkins EB, Lass?gue B, Griendling KK, Bowen JP. Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4. Bioorg Med Chem. 2018 03 01; 26(5):989-998.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support